Ray Dalio Bausch Health Companies Inc. Transaction History

Bridgewater Associates, LP

$17.3 Billion
Q3 2024

A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Bridgewater Associates, LP holds 234,823 shares of BHC stock, worth $1.75 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

234,823

Previous 247,776 5.23%

Holding current value

$1.75 Million

Previous $1.73 Million 10.83%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$5.22 - $8.26 $67,614 - $106,991	-12,953 Reduced 5.23%	234,823 $1.91 Million
Q2 2024 Aug 14, 2024	BUY	$6.1 - $10.41 $1.08 Million - $1.85 Million	177,251 Added 251.33%	247,776 $1.73 Million
Q1 2024 May 14, 2024	BUY	$7.77 - $10.61 $118,896 - $162,354	15,302 Added 27.71%	70,525 $748,000
Q4 2023 Feb 14, 2024	SELL	$6.53 - $8.23 $228,151 - $287,547	-34,939 Reduced 38.75%	55,223 $442,000
Q3 2023 Nov 13, 2023	BUY	$7.69 - $9.71 $19,025 - $24,022	2,474 Added 2.82%	90,162 $741,000
Q2 2023 Aug 11, 2023	BUY	$5.72 - $8.8 $71,391 - $109,832	12,481 Added 16.6%	87,688 $701,000
Q1 2023 May 12, 2023	SELL	$6.28 - $9.85 $57,512 - $90,206	-9,158 Reduced 10.86%	75,207 $609,000
Q4 2022 Feb 13, 2023	BUY	$6.09 - $7.93 $39,231 - $51,085	6,442 Added 8.27%	84,365 $529,000
Q3 2022 Nov 10, 2022	SELL	$4.58 - $9.21 $61,303 - $123,275	-13,385 Reduced 14.66%	77,923 $541,000
Q2 2022 Aug 11, 2022	SELL	$7.06 - $23.63 $1.18 Million - $3.95 Million	-167,367 Reduced 64.7%	91,308 $762,000
Q1 2022 May 13, 2022	BUY	$21.6 - $27.79 $2.45 Million - $3.15 Million	113,430 Added 78.1%	258,675 $5.92 Million
Q4 2021 Feb 14, 2022	BUY	$23.0 - $29.01 $1.37 Million - $1.73 Million	59,478 Added 69.35%	145,245 $4.02 Million
Q3 2021 Nov 12, 2021	SELL	$25.04 - $30.06 $739,431 - $887,671	-29,530 Reduced 25.61%	85,767 $2.39 Million
Q2 2021 Aug 13, 2021	SELL	$27.43 - $32.7 $124,230 - $148,098	-4,529 Reduced 3.78%	115,297 $3.39 Million
Q1 2021 May 14, 2021	BUY	$21.37 - $34.38 $876,426 - $1.41 Million	41,012 Added 52.04%	119,826 $3.8 Million
Q4 2020 Feb 12, 2021	BUY	$15.31 - $21.12 $1.21 Million - $1.66 Million	78,814 New	78,814 $1.63 Million
Q2 2020 Aug 12, 2020	SELL	$13.31 - $20.51 $1.51 Million - $2.32 Million	-113,257 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$12.98 - $30.25 $16,990 - $39,597	-1,309 Reduced 1.14%	113,257 $1.74 Million
Q4 2019 Feb 13, 2020	SELL	$18.89 - $31.89 $15,980 - $26,978	-846 Reduced 0.73%	114,566 $3.43 Million
Q1 2019 May 14, 2019	SELL	$20.23 - $26.29 $539,331 - $700,891	-26,660 Reduced 18.77%	115,412 $2.85 Million
Q4 2018 Feb 13, 2019	SELL	$17.64 - $28.32 $490,638 - $787,692	-27,814 Reduced 16.37%	142,072 $2.63 Million
Q3 2018 Nov 13, 2018	BUY	$20.64 - $25.67 $3.51 Million - $4.36 Million	169,886 New	169,886 $4.36 Million

Others Institutions Holding BHC

# of Institutions

254

Shares Held

253M

Call Options Held

5.53M

Put Options Held

16.5M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.7B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track Ray Dalio's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Account